The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Exelixis
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase 3 CELESTIAL trial.
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Agios; Amgen; Antengene; Aptus Clinical; ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb (I); CARsgen Therapeutics; CASI Pharmaceuticals; Celgene; Celgene (I); Celsion; CytomX Therapeutics (I); Daiichi Sankyo; Debiopharm Group; Delcath Systems; Eisai; EMD Serono (I); Exelixis; Gilead Sciences (I); Halozyme; Halozyme (I); Inovio Pharmaceuticals; Ipsen; Medimmune; Merck Serono; Onxeo; PCI Biotech; Roche; Sanofi (I); SERVIER; Silenseed (I); Sillajen; Sirtex Medical; Sirtex Medical; Vicus Therapeutics (I); Yakult Pharmaceutical
Research Funding - Agios (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Exelixis (Inst); Genentech (Inst); Incyte (Inst); Lilly (Inst); MabVax (Inst); MedImmune (Inst); Momenta Pharmaceuticals (Inst); Novartis (Inst); OncoMed (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Polaris
 
Tim Meyer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Research Funding - Bayer (Inst); BTG (Inst); Ipsen (Inst)
 
Ann-Lii Cheng
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Merck Serono; Novartis; Ono Pharmaceutical; ONXEO
Speakers' Bureau - Novartis
Research Funding - Sanofi
 
Anthony El-Khoueiry
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche
Speakers' Bureau - Merrimack
Research Funding - Astex Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline
 
Lorenza Rimassa
Honoraria - Abbvie; AstraZeneca
Consulting or Advisory Role - Amgen; ArQule; Baxter; Bayer; Exelixis; Ipsen; Italfarmaco; Lilly; Sanofi; Sirtex Medical
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Irfan Cicin
No Relationships to Disclose
 
Philippe Merle
No Relationships to Disclose
 
Yen-Hsun Chen
No Relationships to Disclose
 
Joong-Won Park
Honoraria - Bayer; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Merck; Ono Pharmaceutical
 
Jean-Frédéric Blanc
Honoraria - Baxalta/Shire; Bayer Schering Pharma; Gilead Sciences
Consulting or Advisory Role - Baxalta/Shire; Bristol-Myers Squibb; Novartis; Onxeo
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Luigi Bolondi
Honoraria - Bayer; Bracco Diagnostics; Bristol-Myers Squibb; Guerbet; Lilly; Meda Pharmaceuticals; Sirtex Medical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Guerbet; Sirtex Medical
Speakers' Bureau - Bayer; Bracco Diagnostics; Bristol-Myers Squibb; Guerbet; Lilly; Meda Pharmaceuticals; Sirtex Medical
Research Funding - ArQule; Bayer; Bristol-Myers Squibb; Daiichi Sankyo
Travel, Accommodations, Expenses - Bayer; Bracco Diagnostics; Guerbet; Lilly
 
Heinz Josef Klümpen
Consulting or Advisory Role - Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Stephen Lam Chan
Honoraria - Bayer
Consulting or Advisory Role - AstraZeneca/MedImmune; MSD Oncology; Novartis
Speakers' Bureau - Amgen; Bayer; Eisai
Research Funding - Novartis; Sirtex Medical
 
Vincenzo Dadduzio
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Colin Hessel
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Anne E. Borgman-Hagey
No Relationships to Disclose
 
Gisela Schwab
Employment - Exelixis
Leadership - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Robin Kate Kelley
Consulting or Advisory Role - Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst)
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Exelixis (Inst); Lilly (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Target Pharmasolutions (Inst); Tekmira (Inst)